Screener
Balchem BCPC R&D
R&D at other companies
Other financials
Where this comes from
Reported directly by Balchem in its filing.
Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.
The source filing: Balchem’s 10-Q, filed April 30, 2026.
- Filed
- Apr 30, 2026, 4:33 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000009326-26-000018
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Gross margin | 101,084 | 88,168 |
| Operating expenses: | ||
| Selling expenses | 21,096 | 16,926 |
| Research and development expenses | 5,881 | 4,662 |
| General and administrative expenses | 18,481 | 15,565 |
| 45,458 | 37,153 | |
| Earnings from operations | 55,626 | 51,015 |
| Other expenses, net: |
Item 1. Financial Statements (unaudited)
FAQ
- What is Balchem's R&D?
- Balchem (BCPC) reported R&D of $5.88M in Q1 2026.
- How has Balchem's R&D changed year-over-year?
- Balchem's R&D increased by 26.1% year-over-year, from $4.66M to $5.88M.
- What is the long-term trend for Balchem's R&D?
- Over 4 years (2021 to 2025), Balchem's R&D has grown at a 8.2% compound annual growth rate (CAGR), from $13.52M to $18.51M.
- What does R&D mean?
- Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.
Ask your AI about Balchem's r&d.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude